HIGHLIGHTS
- Provided unconflicted transaction advice, evaluated two prospective offers and advised on investment banking selection
- Advised during merger process with WorldCare Clinical to create Voiant, an industry-leading AI-based clinical trial imaging platform.
BACKGROUND
MedQIA, Inc. (MedQIA), a healthcare technology company that leverages AI for clinical trials, sought GHJ's guidance amidst two prospective offers and an evolving industry landscape. The company approached GHJ’s Growth Planning and Strategic Advisory Practice to evaluate its options after receiving two prospective offers from buyers.
GHJ'S APPROACH
After GHJ helped MedQIA evaluate the offers on the table, the client decided to shop the business more broadly. Given that conclusion, GHJ’s Growth Planning and Strategic Advisory Practice advised the client MedQIA on the selection of an investment banking firm. GHJ acted as a sounding board throughout the merger process by providing continuous support to help with navigating a complex transaction and ensuring a smooth transition.
RESULTS
After a thorough search, a merger of entities took place between MedQIA and WorldCare Clinical, a leading independent contract research organization dedicated to imaging in clinical trials. The successful merger materialized into Voiant, a groundbreaking AI-based clinical trial imaging platform.
“GHJ's comprehensive approach and expertise have been invaluable. Their strategic guidance ensured a successful outcome and positioned MedQIA for long-term success as part of Voiant,” said MedQIA co-founder Jonathan Goldin.
GHJ is committed to partnering with clients like MedQIA to navigate complex transactions and achieve their strategic goals. By providing unconflicted advice and strategic guidance, GHJ ensures successful outcomes that position clients for long-term success in their respective industries.
